deltatrials
Completed NA INTERVENTIONAL 7-arm NCT02778425

The Treatment of Hepatocirrhosis and Portal Hypertension

Partial Splenic Embolization Combined with Endoscopic Therapies and NSBB Decreases the Variceal Rebleeding Rate and Increases Recompensation Rate in Cirrhosis Patients with Hypersplenism: a Multicenter Randomized Controlled Trial

Sponsor: Jinan Military General Hospital

Conditions Hepatic Cirrhosis Portal Hypertension
Interventions Endoscopic therapy Endoscopic therapy+ PSE Endoscopic therapy+ PSE+beta blockers Endoscopic therapy+ beta blockers Somatostatin+Endoscopic therapy Somatostatin+Endoscopic therapy+PSE beta blockers
Updated 10 times since 2017 Last updated: Feb 11, 2025 Started: Feb 29, 2016 Primary completion: Dec 31, 2019 Completion: Jan 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02778425, this NA trial focuses on Hepatic Cirrhosis and Portal Hypertension and remains completed. Sponsored by Jinan Military General Hospital, it has been updated 10 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotRecruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotRecruiting~Oct 2018 – ~Oct 2020 · 24 months · monthly snapshotRecruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotUnknown Status~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotCompleted~Mar 2025 – present · 16 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Mar 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Mar 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Oct 2021 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  5. Jan 2021 — Oct 2021 [monthly]

    Unknown Status NA

▶ Show 5 earlier versions

  1. Oct 2020 — Jan 2021 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  2. Oct 2018 — Oct 2020 [monthly]

    Recruiting NA

  3. Jun 2018 — Oct 2018 [monthly]

    Recruiting NA

  4. Jun 2017 — Jun 2018 [monthly]

    Recruiting NA

  5. Jan 2017 — Jun 2017 [monthly]

    Recruiting NA

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jinan Military General Hospital
  • Shandong Provincial Hospital
  • Yanjing Gao
Data source: Qilu Hospital of Shandong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations